Applications of Artificial Intelligence and Deep Learning in Glaucoma

Author:

Chen Dinah12ORCID,Ran Emma Anran3,Tan Ting Fang45,Ramachandran Rithambara6,Li Fei37,Cheung Carol3,Yousefi Siamak8,Tham Clement C.Y.910,Ting Daniel S.W.4511,Zhang Xiulan37,Al-Aswad Lama A.12ORCID

Affiliation:

1. Department of Ophthalmology, NYU Langone Health, New York City, NY

2. Genentech Inc, South San Francisco, CA

3. State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China

4. Singapore Eye Research Institute, Singapore

5. Singapore National Eye Center, Singapore

6. Kellogg Eye Center, University of Michigan, Ann Arbor, MI

7. Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China

8. Department of Ophthalmology, The University of Tennessee Health Science Center, Memphis, TN

9. Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China

10. Lam Kin Chung, Jet King-Shing Ho Glaucoma Treatment And Research Centre, The Chinese University of Hong Kong, Hong Kong, China

11. Duke-NUS Medical School, National University of Singapore, Singapore

12. Visi Health Technologies Inc, New York City, NY

Abstract

Diagnosis and detection of progression of glaucoma remains challenging. Artificial intelligence–based tools have the potential to improve and standardize the assessment of glaucoma but development of these algorithms is difficult given the multimodal and variable nature of the diagnosis. Currently, most algorithms are focused on a single imaging modality, specifically screening and diagnosis based on fundus photos or optical coherence tomography images. Use of anterior segment optical coherence tomography and goniophotographs is limited. The majority of algorithms designed for disease progression prediction are based on visual fields. No studies in our literature search assessed the use of artificial intelligence for treatment response prediction and no studies conducted prospective testing of their algorithms. Additional challenges to the development of artificial intelligence–based tools include scarcity of data and a lack of consensus in diagnostic criteria. Although research in the use of artificial intelligence for glaucoma is promising, additional work is needed to develop clinically usable tools.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference153 articles.

1. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis;Tham;Ophthalmology,2014

2. Interpreting deep learning studies in glaucoma: unresolved challenges;Lee;Asia Pac J Ophthalmol (Phila),2021

3. Burden of undetected and untreated glaucoma in the United States;Shaikh;Am J Ophthalmol,2014

4. Telemedicine and diabetic retinopathy: review of published screening programs;Tozer;J Endocrinol Diabetes,2015

5. Impact and challenges of integrating artificial intelligence and telemedicine into clinical ophthalmology;Ramessur;Asia Pac J Ophthalmol (Phila),2021

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3